Compound - the compound known as Gaboxadol (INN) with the chemical name, structural formula and CAS Registry Number set forth in [Schedule B].
Royalties for Non-Valid Claim, Acquired Company Compound Products. In consideration for the rights granted hereunder, in each calendar quarter during the Term in which Denali records Net Sales of Company Products not covered by a Valid Patent Claim which incorporate a Company Compound that was licensed or acquired by Denali as described in Section 1.8(iii) (each an Acquired Company Compound Product), and subject to and in accordance with the terms and conditions of this Agreement, Denali shall pay to on a Licensed Product-by-Licensed Product and country-by-country basis an amount as a percentage of annual worldwide Net Sales equal to # of annual Net Sales of such Acquired Company Compound Product if the applicable Company Compound was acquired or licensed by Denali , and # of annual Net Sales of such Acquired Company Compound Product if the applicable Company Compound was acquired or licensed by Denali .
For clarity, GFB is not granting any license to Karuna with respect to any compound included in a Licensed Product that is not a Licensed Compound.
relates to any Licensed Compound or Licensed Product or to the Development, Commercialization or Manufacture in the Territory or use of any Licensed Compound or Licensed Product.
Beginning with IND acceptance, each milestone may be paid up to two times if different compounds are developed in different therapeutic areas, (e.g., one in neuropathy and one in cancer). If a back-up or replacement compound is substituted for an initial lead compound in a given indication, milestones achieved with the back-up or replacement compound will not be payment-bearing until a previously unpaid milestone is reached. For example, if the initially developed compound has entered Phase I and is then replaced, no milestone payments will be due for the replacement compound until first patient randomization in a Phase II trial is achieved.
(b) Denali Patents means those Patents, filed by or on behalf of Denali before the Effective Date or during the Term of this Agreement, having claims or disclosure therein directed to a Compound , method of using a Compound for the treatment or prevention of Parkinsons Disease, or a method of synthesizing a Compound;
Until the Current Compound Inventory is depleted or for as long as Lundbeck manufactures Compound (whichever is longer), Lundbeck shall have the responsibility to provide data, information and other documentation related to its manufacture of Compound as is necessary to prepare its DMF. Ovid will be solely responsible for the preparation of all other regulatory documentation required to obtain Regulatory Approval for Products throughout the Territory. Ovid shall be entitled to cross-reference Lundbecks DMF for the Compound in regulatory filings for Products.
Neuren reserves the non-exclusive right under the Neuren IP to manufacture Compound or Product or have Compound or Product manufactured on its behalf inside the Territory (and to the extent applicable import, export, transport, obtain customs clearance, warehouse, invoice, handle and deliver), provided that the Compound or Product is not sold, transferred, otherwise disposed of, used or supplied for use inside the Territory and is used solely for the purpose of making, having made, using, developing, selling, offering for sale, importing, exporting and otherwise Commercializing such Compound or Product outside the Territory.
Royalty Rates for Licensed Product Containing the Lead Compound. As further consideration for the rights granted to [[Organization A:Organization]] hereunder, subject to Section 6.5.3, commencing upon the First Commercial Sale of a Licensed Product containing the Lead Compound in the Royalty Territory, on a Licensed Product-by-Licensed Product basis, [[Organization A:Organization]] shall pay to a royalty on Net Sales of each Licensed Product containing the Lead Compound in the Royalty Territory (excluding Net Sales of each such Licensed Product containing the Lead Compound in any country or other jurisdiction in the Royalty Territory for which the Royalty Term for such Licensed Product containing the Lead Compound in such country or other jurisdiction has expired) during each Calendar Year at the following rates:
Combination Product shall mean a Licensed Product which includes one or more active ingredients, other than Licensed Compound, in combination with Licensed Compound. All references to Licensed Product in this Agreement shall be deemed to include Combination Product.
AllDrafts is a cloud-based editor designed specifically for contracts. With automatic formatting, a massive clause library, smart redaction, and insanely easy templates, it’s a welcome change from Word.
And AllDrafts generates clean Word and PDF files from any draft.